Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Pediatrics ; 123(1): 143-7, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19117873

RESUMEN

Cerebrotendinous xanthomatosis is an autosomal recessive disease of bile acid synthesis caused by 27-hydroxylase deficiency. Treatment with chenodeoxycholic acid normalizes cholestanol concentrations and abrogates progression of the disease. We present 4 patients with cerebrotendinous xanthomatosis within 1 family who were treated with chenodeoxycholic acid for 14 years. Two young sisters started treatment at the preclinical stage before the appearance of major symptoms. Their 2 older uncles, who had already developed the complete phenotypic form of cerebrotendinous xanthomatosis when diagnosed, commenced treatment at the same time as the sisters, thus establishing a natural control group. After 14 years of chenodeoxycholic acid therapy, the cholestanol levels of all 4 patients decreased to normal levels (<6 microg/mL). Both sisters remained asymptomatic. Only moderate improvement in symptoms was observed in their uncles. In this long-term study, prompt preclinical administration of chenodeoxycholic acid in early childhood completely prevented the cerebrotendinous xanthomatosis phenotype in 2 sisters. Pediatricians should be aware of this diagnostic possibility of cerebrotendinous xanthomatosis in children presenting with chronic diarrhea and juvenile cataracts. Prevention is particularly significant in light of the availability of early genetic diagnosis and the devastating effects of this illness if not treated.


Asunto(s)
Catarata/diagnóstico , Ácido Quenodesoxicólico/uso terapéutico , Diarrea/diagnóstico , Xantomatosis Cerebrotendinosa/diagnóstico , Xantomatosis Cerebrotendinosa/tratamiento farmacológico , Adolescente , Adulto , Ácidos y Sales Biliares/antagonistas & inhibidores , Ácidos y Sales Biliares/biosíntesis , Catarata/tratamiento farmacológico , Catarata/genética , Preescolar , Enfermedad Crónica , Diagnóstico Diferencial , Diarrea/tratamiento farmacológico , Diarrea/genética , Femenino , Humanos , Masculino , Mutación , Linaje , Prevalencia , Tiempo , Xantomatosis Cerebrotendinosa/epidemiología , Xantomatosis Cerebrotendinosa/genética , Adulto Joven
2.
Genet Med ; 10(12): 903-9, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19092443

RESUMEN

PURPOSE: The Druze community is characterized by consanguinity and endogamy, and by reluctance to genetic testing and technological interventions for the prevention of birth defects. Multiple patients with four rare and severe inborn errors of metabolism cerebrotendinous xanthomatosis, prolidase deficiency, argininosuccinate lyase deficiency, and carbamyl phosphate synthetase I deficiency were identified in an isolated Druze village in northern Israel. The aims of this study were to identify couples at risk for four inherited diseases, and to prevent birth defects in a community presenting religious and cultural obstacles to genetic testing. METHODS: A genetic screening and counseling program in a high-risk community. RESULTS: The 1425 residents who attended group genetic counseling sessions between 2003 and 2007 consented to genetic testing. We identified 217 carriers for either one or two disease causing mutations. High carrier frequencies for cerebrotendinous xanthomatosis, prolidase deficiency, argininosuccinate lyase deficiency, and carbamyl phosphate synthetase I deficiency were identified as 1:11, 1:21, 1:41, and 1:95, respectively. Fifty-eight percent (125) of the carriers' spouses agreed to genetic counseling and testing. Ten couples at risk for affected offspring were identified and offered prenatal genetic counseling and diagnosis. CONCLUSIONS: The genetic screening program, the first of its kind reported in a Druze community, was well received. We expect this program to increase awareness of genetic counseling, to contribute to disease prevention, and to serve as a model for other isolated communities.


Asunto(s)
Pruebas Genéticas , Argininosuccinatoliasa/genética , Aciduria Argininosuccínica , Enfermedad por Deficiencia de Carbamoil-Fosfato Sintasa I/diagnóstico , Enfermedad por Deficiencia de Carbamoil-Fosfato Sintasa I/genética , Enfermedad por Deficiencia de Carbamoil-Fosfato Sintasa I/prevención & control , Consanguinidad , Dipeptidasas/deficiencia , Dipeptidasas/genética , Femenino , Asesoramiento Genético , Humanos , Medio Oriente/etnología , Grupos de Población/etnología , Grupos de Población/genética , Xantomatosis Cerebrotendinosa/diagnóstico , Xantomatosis Cerebrotendinosa/genética , Xantomatosis Cerebrotendinosa/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...